Bnp Paribas Asset Management Holding S.A. Ocular Therapeutix, Inc Transaction History
Bnp Paribas Asset Management Holding S.A.
- $41 Billion
- Q2 2025
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 991 shares of OCUL stock, worth $11,594. This represents 0.0% of its overall portfolio holdings.
Number of Shares
991Holding current value
$11,594% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding OCUL
# of Institutions
207Shares Held
137MCall Options Held
743KPut Options Held
321K-
Deep Track Capital, LP Greenwich, CT14.3MShares$167 Million4.71% of portfolio
-
Summer Road LLC West Palm Beach, FL13.9MShares$162 Million98.75% of portfolio
-
Vr Adviser, LLC New York, NY12.8MShares$149 Million23.46% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$135 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.39MShares$98.2 Million0.0% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $901M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...